Director's Corner

Advancing Women’s Health: Research to Reduce Maternal Mortality and Morbidity

NICHD Director Dr. Diana Bianchi observes during an NIH HEAL Initiative meeting. Posted on 03/06/2020

NICHD is working with the Department of Health and Human Services and the National Institutes of Health to enhance coordinated activities addressing the problem of maternal morbidity and mortality.

Addressing opioid withdrawal in newborns, improving pain management for women

NICHD Director Dr. Diana Bianchi observes during an NIH HEAL Initiative meeting. Posted on 02/03/2020

I recently joined NIH Director Dr. Francis Collins, HHS Secretary Alex Azar, and Surgeon General Vice Admiral Jerome to highlight the integral role NICHD plays through our ACT NOW initiative.

Reflecting on 2019

Infocard with NICHD’s new tagline, “Healthy pregnancies. Healthy Children. Healthy and optimal lives.” and the #NICHDStrategicPlan hashtag on the right. On the left, there are colorful circles with images of a rehabilitation patient and nurse, a child eating, an ultrasound of a fetus, a biracial couple and infant, fluorescent cell microscopy, and a female researcher pipetting in the lab. Posted on 01/03/2020

NICHD Director Dr. Diana Bianchi looks back at 2019 and NICHD’s many amazing accomplishments.

Reaching Pregnant Women Through the All of Us Research Program

Posted on 11/14/2019

Two pregnant women smiling with text next them: Get insight into your pregnancy while helping the future of health. Join PregSource. Pregnancy is a time when women are especially curious about their changing bodies and the development of their future child. In an effort to reach more pregnant women, NICHD’s PregSource^® crowdsourcing project is partnering with the All of Us project.

Transforming Down Syndrome Research

Posted on 10/1/2019

NICHD Director Dr. Diana Bianchi stands with Down syndrome research participant David Egan and Dr. Melissa Parisi, chief of the Intellectual and Developmental Disabilities Branch In this busy fall season, NICHD joins a trans-NIH investment into funding for Down syndrome research and research to establish a standard of care for newborns exposed to opioids.